Regulatory News
Wednesday, March 23, 2016
UPDATE 1-U.S. FDA approves Teva's biotech drug for severe asthma
March 23 (Reuters) - The U.S. Food and Drug Administration
said on Wednesday it had approved Teva Pharmaceutical Industries
Ltd's drug to treat asthma in adults who have
a history of severe attacks...
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment